drug · antibody
patient view →pembrolizumab
Marketedupdated 2mo agoby $MRK Merck & Co., Inc.🔗 ChEMBL
Approvedannual revenue · 2024–2024peak $29.5B
community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 9 approved and 146 investigational indications.
indications
investigational
NSCLCMelanoma
targets
Programmed cell death protein 1
all catalysts(100)
approval · 100
News(1)
- Merck adds to pharma’s AI push; Roche details MS drug results<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that